Antenatal health

FIGO disseminates best practice advice and recommendations to support antenatal health, with the aim of reducing morbidity and mortality among pregnant women and their babies around the globe.

Our work focuses on the effects of environmental toxins on maternal health, the prevention and treatment of infections and non-communicable diseases (NCDs) during pregnancy, and foetal health and development.

See below a selection of resources sharing recommendations to support health care providers in ensuring that women’s specific health needs during pregnancy are met.

Toxic chemicals and environmental contaminants in prenatal vitamins

FIGO guidance for sustainable implementation of vaccination programmes for women – pregnancy and HPV

How PFAS chemicals affect women, pregnancy and human development

Special Section from the Safe Motherhood and Newborn Health Committee

Best practice advice for second and third trimester risk stratification, monitoring, and management of pre‐eclampsia

FIGO Initiative on Fetal Growth: Best Practice Advice for Screening, Diagnosis, and Management of Fetal Growth Restriction

FIGO Initiative on Pre‐eclampsia: A Pragmatic Guide for First‐Trimester Screening and Prevention

FIGO Guidelines on Placenta accreta spectrum disorders

FIGO Initiative on Gestational Diabetes Mellitus: A Pragmatic Guide for Diagnosis, Management, and Care